tocilizumab with ipilimumab and nivolumab in unresectable melanoma
Published 3 months ago • 68 plays • Length 1:00Download video MP4
Download video MP3
Similar videos
-
3:16
melanoma patients who discontinued nivolumab and ipilimumab experienced equal or better pfs
-
6:21
new long-term data 'clearly favor' combination ipilimumab/nivolumab in melanoma
-
1:59
checkmate 238: nivolumab versus ipilimumab in stage iii melanoma
-
1:22
dr. sznol discusses the combination of ipilimumab and nivolumab in melanoma
-
2:10
ipilimumab combined with nivolumab for patients with melanoma
-
6:19
should you treat melanoma with nivolumab and relatlimab (opdualag)?
-
1:34
dr. sharpless on managing toxicities with nivolumab/ipilimumab in melanoma
-
1:25
dr. ott discusses ipilimumab and nivolumab in melanoma
-
1:17
dr. shoushtari on the role of nivolumab and ipilimumab in mucosal melanoma
-
2:11
ipilimumab and nivolumab for melanoma brain metastases
-
0:46
the benefits of nivolumab and relatlimab in melanoma
-
1:24
dr. ernstoff discusses nivolumab and ipilimumab in advanced melanoma
-
5:01
melanoma highlights from esmo 2021
-
1:12
current trials in the treatment of melanoma
-
1:28
dr. jeffery s. weber on sequencing of nivolumab, ipilimumab in metastatic melanoma
-
3:24
ipilimumab side effect management in melanoma
-
1:09
areas of unmet need for patients with melanoma
-
1:41
sequencing of immunotherapy in melanoma
-
0:40
dr. schuchter discusses managing ipilimumab's side effects